 ALPHARETTA, Ga., Aug. 03, 2022 GLOBE NEWSWIRE -- Clearside Biomedical, Inc. NASDAQ:CLSD, a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space SCS, announced today that management will participate in the following investor conferences in August 2022: 